News

CROCF

Cell Therapeutics (CTIC) Drops on Technical Factors, Insider Sales

Joel Anderson | Equities.com |

With a rapidly rising support level converging with a hard ceiling of just over $4 a share, it appeared as though something had to give for small-cap biopharmaceutical company Cell Therapeutics



Discover: Trending Events

United Nations
Blockchain for Europe
Humanity 2.0
World Economic Forum


Trending Articles

  • No items found.